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Abstract
This paper investigates whether Chomsky-like grammar representa-
tions are useful for learning cost-eective, comprehensible predictors of
members of biological sequence families. The Inductive Logic Program-
ming (ILP) Bayesian approach to learning from positive examples is used
to generate a grammar for recognising a class of proteins known as hu-
man neuropeptide precursors (NPPs). Collectively, ve of the co-authors
of this paper, have extensive expertise on NPPs and general bioinformat-
ics methods. Their motivation for generating a NPP grammar was that
none of the existing bioinformatics methods could provide suÆcient cost-
savings during the search for new NPPs. Prior to this project experienced
specialists at SmithKline Beecham had tried for many months to hand-
code such a grammar but without success. Our best predictor makes
the search for novel NPPs more than 100 times more eÆcient than
randomly selecting proteins for synthesis and testing them for biological
activity. As far as these authors are aware, this is both the rst biological
grammar learnt using ILP and the rst real-world scientic application of
the ILP Bayesian approach to learning from positive examples.
A group of features is derived from this grammar. Other groups of
features of NPPs are derived using other learning strategies. Amalgams
of these groups are formed. A recognition model is generated for each
amalgam using C4.5 and C4.5rules and its performance is measured us-
ing both predictive accuracy and a new cost function, Relative Advant-
age (RA). The highest RA was achieved by a model which includes
grammar-derived features. This RA is signicantly higher than the best
RA achieved without the use of the grammar-derived features. Predictive
accuracy is not a good measure of performance for this domain because
it does not discriminate well between NPP recognition models: despite
covering varying numbers of (the rare) positives, all the models are awar-
ded a similar (high) score by predictive accuracy because they all exclude
most of the abundant negatives.
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1 Introduction
This paper attempts to answer, by way of a case-study, the question of whether
grammatical representations are useful for learning from biological sequence
data. We address the question with experimental results that signicantly con-
tradict the following null hypothesis.
Null hypothesis: The most cost-eective, comprehensible multi-strategy pre-
dictors of human neuropeptide precursors do not employ a context-free
denite-clause-grammar.
Multi-strategy learning (Michalski & Wnek, 1997) aims at integrating mul-
tiple strategies in a single learning system, where strategies may be inferential
(e.g. induction, deduction etc) or computational. Computational strategy is
dened by the representational system and the computational method used in
the learning system (e.g. decision tree learning, neural network learning etc).
A grammar for a language tells us whether a sentence is properly formed.
Noam Chomsky, a founder of formal language theory, provided an initial clas-
sication of language types. Those readers requiring an introduction to formal
grammars or this hierarchy are referred to (Linz, 1996).
We obtain results which signicantly contradict the null hypothesis as fol-
lows. A grammar is generated for a particular class of biological sequences. A
group of features is derived from this grammar. Other groups of features are
derived using other learning strategies. Amalgams of these groups are formed.
A recognition model is generated for each amalgam using C4.5 and C4.5rules.
The results signicantly contradict the null hypothesis because:-
1. the best performance achieved using any of the models which include
grammar-derived features is higher than the best performance achieved
using any of the models which do not include the grammar-derived fea-
tures;
2. this increase is shown to be statistically signicant;
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3. the best model which includes grammar-derived features is suÆciently
more comprehensible than the best `non-grammar' model.
Performance is measured using a new cost function, Relative Advantage
(RA). Appendix A denes RA and explains why it is used in preference to
other performance measures. A method of estimating the RA of a recognition
model is presented which subsequently allows the statistical signicance of the
dierence between the RA of two models to be gauged.
The domain of the case study is the recognition of a class of proteins known
as human neuropeptide precursors (NPPs). These proteins have considerable
therapeutic potential and are of widespread interest in the pharmaceutical in-
dustry (see Section 3). Our best multi-strategy predictor of NPPs employs a
context-free denite-clause-grammar.
An Inductive Logic Programming (ILP) (Muggleton & Raedt, 1994) system
is used to generate a grammar for NPPs. As far as these authors are aware,
this is the rst attempt to generate a grammar for a biological domain using
ILP. ILP is the area of Articial Intelligence which deals with the induction of
hypothesised predicate denitions from examples and background knowledge.
Logic programs are used as a single representation for examples, background
knowledge and hypotheses. For a recent overview of ILP issues and results see
(Muggleton, 1999).
Most ILP systems require both a set of positive examples of the concept to
be learnt and a set of negative examples. However it is not possible to identify
a large, unbiased set of negative examples of NPPs with certainty because there
will be proteins which have yet to be recognised scientically as a NPP. Therefore
advantage was taken of the ILP Bayesian approach to learning from positive
examples (Muggleton, 1996). This approach does not require a set of negative
examples. It is able to learn a concept from a set of positive examples and a set
of examples sampled at random. As far as these authors are aware, this is the
rst real-world scientic application of this approach.
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The paper is organised as follows. Section 2 describes the role of sequence
information in molecular biology and previous techniques for learning from it, in-
cluding grammatical inference. This section reviews grammatical inference from
the viewpoint of learning cost-eective, comprehensible predictors of members
of biological sequence families. Those readers interested in previous theoretical
results and applications to natural language are referred to (Sakakibara, 1997)
and the references therein. Section 3 introduces neuropeptide precursor recog-
nition, the domain of the case-study. Sections 4 and 5 detail the experimental
materials, methods and results. Section 6 is the Discussion. Appendix A de-
scribes the new cost function Relative Advantage (RA). Appendix B includes
the production rules generated by CProgol. Appendix C includes our best
multi-strategy predictor of NPPs.
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2 Sequence Data in Biology
Research in the biological and medical sciences is being transformed by the
volume of data coming from projects which will reveal the entire genetic code
(genome sequence) of Homo sapiens as well as other organisms. Once complete,
these projects should help us understand the genetic basis of human disease.
The growth in the volume of data and improvements in software for interpreting
this information has increased interest in the use of computational methods for
identifying genes involved in human disease (Rawlings & Searls, 1997). Know-
ing the genes implicated in a disease identies the proteins that they code for
and possibly suggests the biochemical processes that may be inuencing the
development of the disease. This information is crucial for the generation of the
experimental reagents needed for the development of new drugs and explains
the widespread investment by the biotechnology and pharmaceutical industries
in bioinformatics sta and technologies (Lyall, 1996; Spence, 1998).
Recent announcements indicate a commitment to complete sequencing of the
entire human genome during the year 2000, through accelerated international
funding of public research (Pennisi, 1999). This initiative has promoted the
development of technology to generate raw (uninterpreted) gene sequence data
at a rate of at least 1 Gigabase of new DNA per year. Once the full human
genome sequence is available, it will not be long before the nucleotide sequence of
every human gene is known. The amino acid sequences of the proteins encoded
by these genes can then be deduced. Current estimates of the number of genes in
the human genome vary greatly, but tend to average around 60,000. If dierent,
but similar biological sequences are believed to have arisen by evolution from
a common ancestor, the proteins or genes are said to be homologous to each
other. For a signicant portion of these deduced protein sequences, a function
can be inferred due to the homology of the sequence to another known protein.
However, given the large numbers of new protein sequences expected to be solved
in the near future there will be a great many for which no clear homologues of
known function exist.
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Data deposition at this rate will challenge all aspects of the existing genomic
information processing infrastructure in both commercial and academic research
sectors. Current state of the art computational sequence interpretation methods
are not capable of solving the sequence to function problem for all new proteins,
and the development of new techniques is still required.
A signicant challenge in the analysis and interpretation of genetic sequence
data is therefore the accurate recognition of patterns within the data that are
diagnostic for known structural or functional features within the protein. The
language of genes is written in a simple alphabet fA, C, G, Tg representing the
four DNA base codes. The language of proteins uses a twenty character alphabet
fA, C, D, E, F, G, H, I, K, L, M, N, P, Q, R, S, T, V, W, Yg repres-
enting amino acid residues. These residues are encoded in genes by successive
DNA base triplets. At their simplest, these patterns can be described as regular
expressions. Many features can be described through the use of regular expres-
sions and a database PROSITE (Bairoch et al., 1997) is available in which
these patterns are curated. A PROSITE pattern such as:
[AC]-x-V-x(4)-fEDg
is translated as:
[A or C]-any-V-any-any-any-any-fany but E or Dg
A more extensive example of a PROSITE pattern is that for the family of pro-
teins called short-chain dehydrogenases (enzymes involved in cell metabolism).
The PROSITE pattern that includes two perfectly conserved residues, a tyr-
osine (Y) and a lysine (K) is:
[LIVSPADNK]-x(12)-Y-[PSTAGNCV]-[STAGNQCIVM]-[STAGC]-K-fPCg-[SAGFY-
R]-[LIVMSTAGD]-x(2)-[LIVMFYW]-x(3)-[LIVMFYWGAPTHQ]-[GSACQRHM]
There are, however, limitations inherent in the use of simple regular expres-
sions as a representation of biological sequence patterns. In recent years atten-
tion has shifted towards both the use of neural network approaches (see (Baldi
& Brunak, 1998)) and to probabilistic models, in particular hidden Markov
models (see (Durbin et al., 1998)). Both these methods directly address the
extent of variation in the biological world. A signicant advantage of both the
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probabilistic methods and the neural network approaches is that they are com-
plemented with well-established methods for training models from examples.
Training regimes generally (but not always) require that the sequences in the
training set be arranged so that those regions of the sequence that have been
conserved through evolution are aligned in the same column. The accurate mul-
tiple alignment of biological sequences has been the subject of much research
and discussion (Doolittle, 1996)), and is considered by many to be a solved
problem. However, it relies on the assumption that the sequences to be aligned
show some homology at the sequence level with each other. Complex biological
signals also require complex models and it is often the case that considerable
expertise is required in the selection of the optimal neural network architecture
or hidden Markov model before training can take place.
A general linguistic approach to representing the structure and function of
genes and proteins has intrinsic appeal as an alternative approach to probabil-
istic methods because of the declarative and hierarchical nature of grammars.
Searls (Searls, 1993) has undertaken the most thorough analysis of the linguistic
classication of genetic grammars starting with the Denite Clause Grammar
(DCG). Searls proposes a String Variable Grammar (SVG) extension to a DCG
to provide features necessary for representing higher-order interactions among
genetic sequence elements found in nucleic acids such as non-linear features
found in RNA pseudoknots and other secondary structures formed as a result
of internal nucleic acid base-pairing.
While linguistic methods have provided some interesting results in the recog-
nition of complex biological signals (Searls, 1997) general methods for learning
new grammars from example sentences are much less developed. Brazma has
reviewed the development of methods for the automatic discovery of biological
patterns (Brazma et al., 1998) much of which has taken place in the context of
building databases of sequence motifs such as PROSITE (Bairoch et al., 1997),
BLOCKS (Heniko & Heniko, 1996) and PFAM (Sonnhammer et al., 1997;
Sonnhammer et al., 1998). Abe & Mamitsuka proposed a method for predicting
the protein secondary structure of a given amino acid sequence using a training
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algorithm for a class of stochastic tree grammars (Abe & Mamitsuka, 1997).
We considered it valuable to investigate the application of Inductive Logic
Programming methods to the discovery of a language that would describe a par-
ticularly interesting class of sequences { neuropeptide precursor proteins (NPP).
They are highly variable in length and undergo specic enzymatic degradation
(proteolysis) before the biologically active short peptides (neuropeptides) are
released. Unlike enzymes or structural proteins, NPPs tend to show almost no
overall sequence similarity with the exception of some evidence for common an-
cestry within certain groups. Roughly, the 50 human neuropeptide precursors
currently known contain about 140 known cleaved peptides. These peptides
belong to at least 40 dierent neuropeptide families, with only 1-5 members per
family. Prosite motifs do exist for some of the more highly populated families,
but these are based on the cleaved peptide and not the precursor. These mo-
tifs could be used to discover new members of a neuropeptide family, but they
will never detect novel families of neuropeptides. It is believed that there are a
great many more novel subgroups yet to be discovered. This confounds pattern
discovery methods that rely on multiple sequence alignment and recognition of
biological conservation. As a consequence NPPs pose a particular challenge in
sequence pattern discovery and recognition.
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3 Neuropeptide Precursor Proteins
Neuropeptides are an important group of short proteins that act as neuro-
transmitters mediating the passage of signals within the central nervous system
(CNS) and between the CNS and the rest of the body. The term neuropeptide
was rst introduced in 1971 by D. de Weid (Klavdieva, 1995) to describe frag-
ments of hormones that produced behavioural changes when injected, but lacked
the activity of the intact hormone. More recently the term has been accepted
to cover peptides united by a number of common features, including their tis-
sue expression (brain, nervous tissue, secretory cells from organs such as gut,
heart, lungs, placenta etc) metabolism, secretion, biosynthesis and high potency
(Klavdieva, 1995).
Drug molecules work by interacting with target sites within the body. These
sites commonly are protein molecules, either enzymes or receptors. By interac-
tion with these protein molecules, drugs can modulate their actions and gen-
erally suppress undesirable biochemical reactions. Neuropeptides exert their
biological actions through binding as ligands to specic receptors. The term
ligand is used for molecules which bind to the target site. (A ligand might be
highly active against the target, but not a `drug', because of a lack of other
required properties such as metabolic stability or safety.)
Active research has increased the number of mammalian neuropeptides from
about 18 in 1978 to more than 80 by 1999. However, despite all these eorts, the
biology of many of these neuropeptides as well as their interactions with their
receptors remain to be elucidated. The receptors of some neuropeptides have not
yet been identied and there are some orphan receptors with as yet unidentied
ligands. The in-vitro pairing of a novel receptor with its ligand is a critical
rst step in understanding the mechanism of disease. Thus novel neuropeptides
and their orphan receptors have considerable therapeutic potential and are of
widespread interest in the pharmaceutical industry.
Neuropeptides are subsequences of neuropeptide precursor sequences. An
example of a neuropeptide precursor is shown in Figure 1. This neuropeptidePut
Fig 1
here
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precursor contains the neuropeptides Angiotensin I and Angiotensin II. A dia-
grammatic representation of several other precursors is shown in Figure 2.
Precursors may contain either a single neuropeptide, multiple copies of the samePut
Fig 2
here
neuropeptide or several dierent neuropeptides. These can occur consecutively
in the precursor or can be separated by large stretches of ller peptide which
is believed to play a purely structural role. Neuropeptide precursors contain
a short prex of residues called a signal peptide of about 20{30 amino acids
(aa) in length. The known precursors range in length from 70 to 600 aa, and
the cleaved peptides range from 3-200 aa. It is this huge variation in length,
sequence and internal organisation that makes neuropeptide precursors diÆcult
to use when searching for novel remote homologues using sequence database
searching methods (e.g. BLAST). They also confound typical multiple sequence
alignment methods used to identify conserved features among functionally re-
lated sequences.
Many proteins are cleaved and trimmed after synthesis. For example, di-
gestive enzymes are synthesised as inactive precursors that can be stored safely
in the pancreas. After being released into the intestine, these precursors become
activated by cleavage. Neuropeptide precursors undergo this `splitting' process.
The signal peptide targets the protein for secretion through a cell membrane
where it is then cleaved from the precursor. The remainder of the precursor is
further cleaved to release the neuropeptide. Within the precursor, the location
of the cleavages of the signal sequence and the neuropeptides are referred to as
cleavage sites.
To our knowledge there has been no previous attempt to computationally
predict or recognise neuropeptides. Several investigators have statistically ana-
lysed various features of neuropeptides and their precursors (Devi, 1991; Rholam
et al., 1995; Rholam et al., 1986; Bakalkin et al., 1991). Other investigat-
ors have developed methods for the identication of protein sorting signals and
the prediction of their cleavage sites (Claros et al., 1997; Nielsen et al., 1999;
Nielsen et al., 1997). However the recognition of signal peptides only solves part
of the problem of how to recognise neuropeptide precursors. Within SmithK-
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line Beecham our previous work in predicting novel neuropeptide precursors has
centred on the use of regular expression searching of translated Expressed Se-
quence Tag (EST) databases of gene fragments. The results of this approach
were limited by the rigidity of the regular expressions, the high frequency of
errors in EST sequences (Hillier et al., 1996), and their relatively short length.
The ultimate goal of this project will be to dierentiate novel neuropeptides
from the wealth of other new sequences produced by the completion of the hu-
man genome sequencing project. This is a task that current sequence analysis
tools have so far failed to solve.
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4 Experiment One
This section describes an experiment whose results signicantly contradict the
null hypothesis (see Section 1). The section begins by describing the mater-
ials (data, background knowledge and machine learning systems) used in the
experiment. This is followed by an account of the three steps of the experi-
mental method. Finally the section ends with the presentation and analysis of
the results.
4.1 Materials
4.1.1 Data
The data was taken from the SWISS-PROT database (Bairoch & Apweiler,
2000). SWISS-PROT is an annotated protein sequence database established in
1986 and maintained, with collaborators, by the Department of Medical Bio-
chemistry of the University of Geneva. It can be accessed at
http://www.expasy.ch/sprot/sprot-top.html.
Our data-set comprises a subset of positives i.e. known NPPs and a subset
of randomly-selected sequences. It is not possible to generate a large, unbiased
set of negative examples because there will be proteins which have yet to be
recognised scientically as a NPP. The characteristics of the two subsets of
sequences are as follows.
Positives This subset contains all of the 44 known NPP sequences that were
in SWISS-PROT in Spring 1997, the time the data-set was prepared (see
Table 8). The SWISS-PROT identiers of these 44 sequences are listed in
Tables 1 and 2.Put
Tab 1
and
Tab 2
here
All but three of these are human proteins. The three non-human se-
quences were included as the human equivalent had not been discovered
and they were considered to be important examples. They are expected to
be very closely related to the human and are possibly a reasonable model
for humans.
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10 of the 44 precursors were selected to constitute part of the test-set.
These sequences are unrelated by sequence homology to the remaining 34.
Randoms This subset contains all of the 3910 full length human sequences in
SWISS-PROT in Spring 1997.
1000 of the 3910 randoms were reserved for the test-set.
The data-set is available at
ftp://ftp.cs.york.ac.uk/pub/aig/Datasets/neuropeps/
4.1.2 Machine Learning Systems
The propositional learning was performed using the decision-tree learner C4.5
(Release 8) in conjunction with the companion program C4.5rules that con-
structs rules from a tree built by C4.5 (Quinlan, 1993). The grammar learning
was performed using CProgol (Muggleton, 1995) version 4.4 which is available
from
ftp://ftp.cs.york.ac.uk/pub/ML GROUP/progol4.4.
4.1.3 Background Knowledge
During both the generation of the grammar using CProgol and the generation
of propositional rule-sets using C4.5 and C4.5rules we adopt the background
information used in (Muggleton et al., 1992) to describe physical and chemical
properties of the amino acids (see Table 3).Put
Tab 3
here
4.2 Method
The method may be summarised as follows:-
1. A grammar is generated for NPP sequences using CProgol (see Section 4.2.1).
2. A group of features is derived from this grammar. Other groups of features
are derived using other learning strategies. (See Section 4.2.2).
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3. Amalgams of these groups are formed. A rule-set is generated for each
amalgam using C4.5 and C4.5rules and its performance is measured us-
ing Mean RA. This is a new cost function which is described in Ap-
pendix A. The null-hypothesis (see Section 1) is then tested by comparing
the Mean RA achieved from the various amalgams. (See Section 4.2.3).
4. A hidden Markov model (HMM) is generated for NPP sequences and its
Mean RA is measured (see Section 4.2.4).
4.2.1 Grammar Generation
A NPP grammar contains rules that describe legal neuropeptide precursors.
Figure 3 shows an incomplete example of such a grammar, written as a PrologPut
Fig 3
here
program. This section describes how production rules for signal peptides and
neuropeptide starts, middle-sections and ends were generated using CProgol.
These were used to complete the context-free denite-clause-grammar structure
shown in Figure 3. The start and end represent cleavage sites and the middle-
section represents the mature neuropeptide i.e. what remains after cleavage has
taken place.
The production rules to be learnt by CProgol contains dyadic predicates of
the form p(X,Y), which denote that property p began the sequence X and is
followed by a sequence Y. To learn such rules from the the training-set, CProgol
was provided with the following extensional denitions:
Precursor data. Using details of the start and nishing positions for signal
peptides and neuropeptides it was possible to generate examples of non-
terminals as below:
signalpep(S,[]) where S is a list of precursor residues constituting the
signal peptide.
start(S,[]) where S is a list of residues constituting the start of a
neuropeptide. The length of S was taken to be 2 residues.
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middle(S,[]) where S is a list of residues constituting the middle of a
neuropeptide. The starting residue for S is the rst residue after the
end of the sequence for start/2 above. The end of S was taken to
be 3 residues from the last position of the neuropeptide.
end(S,[]) where S is a list of 3 precursor residues constituting the end of
a neuropeptide. S commences with the residue after the end of the
sequence for middle/2 above.
Random data. One random example for each of signalpep/2, start/2, middle/2
and end/2 was generated from each sequence in the set of randoms se-
quences. Random examples are distinguished by the prex *.
*signalpep(S,[]) where S is a list of residues starting at the rst po-
sition in the sequence. The length of S is obtained from drawing
randomly from the distribution of signal peptide lengths of NPPs in
the training data.
*start(S,[]) where S is a pair of sequence residues. The starting residue
is randomly chosen, and is ensured not to conict with the sequence
chosen for *signalpep/2 above.
*middle(S,[]) where S is a list of residues starting after the end of the
sequence for *start/2 above. The length of S is obtained by drawing
randomly from the length of neuropeptide middle-sections of precurs-
ors in the training data.
*end(S,[]) where S is a list of 3 residues starting at the end of the
sequence terminating the denition of *middle/2 above.
CProgol was provided with denitions of the non-terminals star/2 and
run/3 (see Table 14). star/2 represents some sequence of unnamed residues
whose length is not specied. run/3 represents a run of residues which share a
specied property.
The grammar-based approach presents a powerful method for describing
NPPs, as it allows for the natural inclusion of existing biochemical knowledge.
16
Prior knowledge of NPPs suggested that the following subsequences may be
important: KR; GKR and GRR. The subsequences KR and GKR are established pro-
teolytic cleavage sites found in NPPs; GRR is a relatively common alternative
cleavage site to GKR. Pilot experiments suggested that the following patterns
may be signicant:
K,positive;
positive,positive;
Y,very hydrophobic;
hydrophilic,a gap of some residues,M,negative;
HP;
WMDF.
All these subsequences and patterns were coded as Prolog predicates and
included as background knowledge (see Table 14).
Other pilot experiments on the training data showed that the accuracy of
CProgol's grammar was higher with certain restrictions on the length of NPPs,
signal peptides and neuropeptides. Specic constraints were obtained by pro-
gressively checking the following: all lengths less than the mean length on train-
ing data; lengths that are within 1; 2; : : : standard deviation of the mean on
training data. This resulted in the following additional restrictions: (1) NPP
lengths not to exceed 200 residues; (2) signal peptide lengths to be between 19
and 29 residues; and (3) middle-sections of neuropeptides lengths to be between
4 and 52 residues. These constraints only aect the values of features derived
from the grammar. They do not constrain the value of the sequence length
feature described at the end of Section 4.2.2.
Appendix B shows the mode and type declarations, settings and prune pre-
dicates that were needed to enable CProgol to complete the grammar shown in
Figure 3. Table 13 shows the production rules that were generated.
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4.2.2 Feature Groups
The grammar features Predictions about a NPP sequence can be made by
parsing it using the NPP grammar. The values of the features shown in
Table 4 were obtained by such parses. Note that whenever the grammarPut
Tab 4
here
predicts that a sequence is not a NPP, all of the features are assigned the
value zero .
The SIGNALP features Each feature in this group is a summary of the res-
ult of using the SIGNALP program on a sequence. The SIGNALP pro-
gram (Nielsen et al., 1997) represents the pre-eminent automated method
for predicting the presence and location of N-terminal signal peptides.
SIGNALP is available on the web at
http://www.cbs.dtu.dk/services/SignalP.
The technique used combines the predictions of two dierent neural net-
works groups { one that recognises cleavage sites, and the other that
identies signal peptides. When provided with a sequence of N-terminal
residues, the following are reported as summaries: (a) C scores: which
consist of the maximum value of the score from the cleavage-recogniser,
the position in the sequence where this value is achieved, and a nominal
`y' or `n' denoting the answer to whether a cleavage site is present; (b) S
scores: the corresponding values from the signal-peptide recogniser; (c) Y
scores: a score that combines the C and S scores; and (d) Mean scores: a
mean of the S-score and S-conclusions from the N-terminal end to the pre-
dicted cleavage site. For the experiments here, SIGNALP was provided
with 50 amino acids from the N-terminal for each sequence. The sum-
maries were extracted and represented by 11 features shown in Table 5.
Put
Tab 5
here
The proportions features Each feature in this group is a proportion of the
number of residues in a given sequence which either are a specic amino-
acid or which have a specic physicochemical property of an amino-acid.
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Hence there is one such feature for each of the a) 20 amino acids b) prop-
erties shown in Table 3.
The sequence length feature This feature is the length of the sequence. In
the remainder of this paper this feature will be referred to as length.
4.2.3 Propositional Learning
The training and test data sets for C4.5 were prepared as follows.
1. Recall from Section 4.1.1 that our data comprises 44 positives and 3910
randoms. 40 of the 44 positives occur in the set of 3910 randoms. As C4.5
is designed to learn from a set of positives and a set of negatives, these
40 positives were removed from the set of randoms. Of the 40 positives
which are in the set of randoms, 10 are in the test-set. Hence the set of
(3910  40) sequences were split into a training-set of (2910  30 = 2880)
and a test-set of (1000  10 = 990).
2. Values of the features were generated for each training and test sequence.
Each sequence was represented by a data vector comprised of these feature
values and 1 class value (`1' to denote a NPP and `0' otherwise).
3. Finally to ensure that there were as many `1' sequences as `0' sequences
a training-set of 2880 NPPs was obtained by sampling with replacement.
Thus the training data-set input to C4.5 comprised (2 2880) examples.
(No re-adjusting was done on the test data.)
Amalgams of the feature groups described in the previous section were
formed. The amalgams are listed in Table 6. The following procedure was
followed for each one:-
1. training and test sets were prepared as described above;
2. a decision tree was generated from the training-set using C4.5;
3. a rule-set was generated from this tree using C4.5rules;
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4. a 2  2 contingency table was drawn-up based on the predictions of this
rule-set on the test-set;
5. Mean RA was estimated as described in Appendix A.3.
The default settings of C4.5 and C4.5rules were used.
The contradiction of the null hypothesis was then attempted by testing
whether:-
 the Mean RA of the best model which includes grammar-derived features
was higher than the best performance achieved using any of the models
which do not include the grammar-derived features.
 such an increase was statistically signicant. Estimates ofMean RA were
compared using the statistical method described in Appendix A.4.
 the best model which includes grammar-derived features was suÆciently
more comprehensible than the best `non-grammar' model.
4.2.4 Hidden Markov Model Comparison
AHMM for NPPs was generated and tested using HMMER
1
version 2.1.1 (Eddy,
1998) which is available from http://hmmer.wustl.edu/.
CLUSTAL W (1.8) (Thompson et al., 1994) was used to align the positive
sequences in the training-set. The hmmbuild program of HMMER was then used
to generate a HMM from the CLUSTAL W alignment. The resulting HMM and
the hmmsearch program of HMMER were then used to search for NPPs in the
test-set. The default settings of CLUSTAL W and HMMER were used. The
Mean RA of the HMM was estimated based on the predictions on the test-set.
4.3 Results and Analysis
Table 13 shows the grammar that was generated using CProgol. The gram-
mar is very rich in terms of non-terminals. All but one of the non-terminals
1
The validity of the result was checked with the author of HMMER.
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which represent the properties of residues listed in Table 3 appear in the gram-
mar. The grammar also includes star/2, run/3 and three of the six non-
terminals which represent the patterns mentioned in Section 4.2.1. The non-
terminals yvh and pp, which represent the patterns Y,very hydrophobic and
positive,positive, both appear twice. The third non-terminal which appears
is hmn, which corresponds to the pattern
hydrophilic,a gap of some residues,M,negative.
Table 6 shows that predictive accuracy is not a good measure of performancePut
Tab 6
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for this domain because it does not discriminate well between the amalgams:
despite covering varying numbers of (the rare) positives, all the models are
awarded a similar (high) score by predictive accuracy because they all exclude
most of the abundant negatives.
Table 6 shows theMean RA for both the hidden Markov model and for each
amalgam of feature groups. The Mean RA of the HMM is zero. The highest
Mean RA (107.7) was achieved by one of the grammar amalgams, namely the
`Proportions + Length + SIGNALP + Grammar' amalgam. The bestMean RA
achieved by any of the amalgams which do not include the grammar-derived
features was the 49.0 attained by the `Proportions + Length' amalgam.
The
P
90
M=57
RA for the `Proportions + Length + SIGNALP + Grammar'
amalgam was 3661.376. The
P
90
M=57
RA for the `Proportions + Length' amal-
gam was 1666.733. For the amalgams `Proportions + Length + SIGNALP +
Grammar' and `Proportions + Length', ^
D
= 1994:643 and ^
D
=
p
n = 2:081.
This dierence is statistically signicant: substituting these values of ^
D
and
^
D
=
p
n into Equation 15 shows that p(d < 0) is well below 0.0001.
If one searches for a NPP by randomly selecting sequences from SWISS-
PROT for synthesis and subsequent biological testing then, at most, only one
in every 2408 sequences tested is expected to be a novel NPP. This follows from
the fact that number of sequences in SWISS-PROT = 79449, the most prob-
able number of novel NPPs in SWISS-PROT = 90   57 = 33 (see Table 8)
and 33=79449 = 1=2408. Using our best recognition model as a lter makes
the search for a NPP far more eÆcient. Approximately one in every 22 of the
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randomly selected SWISS-PROT sequences which pass through our lter is ex-
pected to be a novel NPP. This can be seen from the following simple calculation.
Rearranging Equation 2 gives Pr(NPP j Rec) = RA  Pr(NPP ). Substitut-
ing in the MeanRA for the best recognition model gives Pr(NPP j Rec) =
107:688  (90=79449) = 1=8:2. Multiplying 1/8.2 by the proportion of NPPs in
SWISS-PROT which are novel (33/90) gives approximately 1/22.
Appendix C lists the complete rule-sets for the amalgams `Proportions +
Length + SIGNALP + Grammar' and `Proportions + Length'. The rules that
were generated from the `grammar amalgam' suggest that the NPP grammar
is useful for learning from NPP sequence data. Nine of the 25 rules include a
grammar-derived feature. These rules refer to a variety of the grammar-derived
features:-
 whether the grammar predicts the existence of an neuropeptide start (e.g.
see Rule 14 in Figure 5);
 the rst residue in the neuropeptide (e.g. see Rules 20 and 21 in Figures
5 and 6 respectively);
 the position of the rst residue in the neuropeptide (e.g. see Rule 6 in
Figure 5);
 the property of the third from last residue in the neuropeptide (e.g. see
Rule 17 in Figure 5).
 the length of the signal peptide;
Our method did not try to remove the potential redundancy between values
of some of the SIGNALP features and grammar features. The results listed in
Table 6 justify this. It is of interest to note that the grammar-derived length
of signal peptide is used frequently by C4.5 (see Rules 2, 9, 23 and 24), despite
the availability of similar features derived from SIGNALP (see Table 5).
Finally, it should be noted that two of the rules refer only to grammar-derived
features (see Rules 20 and 21).
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5 Experiment Two
Aim The aim of the second experiment is to demonstrate that overtting of
the NPP sequences did not inadvertently occur during the generation of
grammar in the rst experiment (see Section 4.2.1). The data-set used
in the rst experiment contained all of the 44 known NPP sequences in
SWISS-PROT in Spring 1997. The second experiment utilises 13 addi-
tional NPP sequences which had been added to SWISS-PROT by May
1999 (see Table 8). None of these 13 additional NPP sequences were used
for training or testing in the rst experiment. Indeed the identiers of
these 13 sequences were not known to C.H.B (who performed the second
experiment) until after the results of the rst experiment were published
(Muggleton et al., 2000).
Data Two test-sets are used in this experiment.
1. The test-set used in the rst experiment i.e. the one which contains
10 of the 44 original NPPs and the 990 'other' sequences.
2. A new test set comprising the 990 'other' sequences from the test-set
used in the rst experiment and 10 of the 13 additional NPP se-
quences which had been added to SWISS-PROT by May 1999. The
SWISS-PROT identiers of the additional 13 sequences are listed in
Table 7 and the sequences are available at
ftp://ftp.cs.york.ac.uk/pub/aig/Datasets/neuropeps/. Three
of the 13 additional NPP sequences (P10092, P07492 and Q00072)
were not used as they are homologues of NPPs in the original training
set of 34 NPPs.
Method The MeanRA of the grammar on both the original test-set and the
new test-set was measured. Note that it was theMeanRA of the grammar
generated by CProgol that was measured as opposed to one of the decision
trees generated by C4.5 and C4.5rules. MeanRA was estimated using the
method described in Section A.3.
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Result TheMeanRA of the grammar was the 5.6 for both the original test-set
and the new test-set.
Conclusion Overtting of the original set of NPP sequences did not occur dur-
ing the generation of the grammar: the performance of the grammar on
the new and original data-sets is the same. This result provides further
evidence to support our conclusion that we have developed a NPP recog-
nition method which would provide cost-savings during a search for novel
NPPs.
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6 Discussion
This paper has shown that the most cost-eective, comprehensible multi-strategy
predictor of human neuropeptide precursors does employ a context-free denite-
clause-grammar.
The ILP Bayesian approach to learning from positive examples was used
to generate a grammar for recognising a class of proteins known as human
neuropeptide precursors (NPPs). Collectively, ve of the co-authors of this pa-
per, have extensive expertise on NPPs and general bioinformatics methods.
Their motivation for generating a NPP grammar was that none of the ex-
isting bioinformatics methods could provide suÆcient cost-savings during the
search for new NPPs. Prior to this project experienced specialists at SmithK-
line Beecham had tried for many months to hand-code such a grammar but
without success. Our best predictor makes the search for novel NPPs more
than 100 times more eÆcient than randomly selecting proteins for syn-
thesis and testing them for biological activity (see Figure 4) . As far as thesePut
Fig 4
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authors are aware, this is both the rst attempt to learn a biological grammar
using ILP and the rst real-world scientic application of the ILP Bayesian
approach to learning from positive examples.
We rst published that our best predictor delivers more than a hundred-
fold cost-saving in the proceedings of seventeenth international conference on
Machine Learning (Muggleton et al., 2000). Since then we have obtained further
evidence to support our conclusion that we have developed a NPP recognition
method which would provide cost-savings during a search for novel NPPs. We
have shown, using NPP sequences which had not been used previously on this
project, that overtting of the original set of NPP sequences did not occur
during the generation of the grammar.
A shortcoming of the NPP grammar generated is that it will not recognise
all NPPs because it implies that 1) both start and end cleavage sites are com-
pulsory; 2) a mature neuropeptide cannot be adjacent to the signal peptide or
at the C-terminus unless it contains a start or an end cleavage site respectively.
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These restrictions could be removed by adding extra clauses to the denition
of the predicates npp/2 and neuro peptide/2 shown in Figure 3. Experiments
with a more exible grammar should therefore form the subject of future work.
In our opinion, the best `non-grammar' recognition model does not provide
any biological insight. However the best recognition model which includes
grammar-derived features is broadly comprehensible and contains some intriguing
associations that may warrant further analysis. This model is being evaluated as
an extension to existing methods used in SmithKline Beecham for the selection
of potential neuropeptides for use in experiments to help elucidate the biological
functions of G-protein coupled receptors. It is clear however, that the rules of
the model are not an optimal representation of sequence data and residue prop-
erties. A more intuitive (e.g. graphically oriented, sequence centred) display of
the meaning of these rules would be required to build tools that the experts in
the eld would nd acceptable.
The new cost function presented in this paper, Relative Advantage (RA),
may be used to measure performance of a recognition model for any domain
where
1. the proportion of positives in the set of examples is very small.
2. there is no guarantee that all positives can be identied as such. In such
domains, the proportion of positive examples in the population is not
known and a large, unbiased set of negatives cannot be identied with
complete condence.
3. there is no benchmark recognition method.
In Appendix A we have developed a general method for assessing the signi-
cance of the dierence between RA values obtained in comparative trials. RA
is estimated by summing the estimate of performance on each test-set instance.
The method uses a) identically distributed random variables representing the
outcome for each instance; b) a sample mean which approaches the population
mean in the limit and c) a relatively small sample variance.
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A Relative Advantage
NPPs are identied either through purely biological means or by screening ge-
nomic or protein sequence databases for likely NPPs, followed by biological
evaluation. If we wish to go beyond using sequence homology to nd new mem-
bers of the (generally small) NPP families, we need a recognition model for
NPPs in general. However if this recognition model is poor then it may not be
much better than random sampling of sequence databases (e.g. SWISS-PROT)
and the cost-benet of any experimental evaluation of NPPs found by such a
procedure would be prohibitively small.
In developing a general recognition model for human NPPs, we are faced
with three signicant obstacles.
1. The number of known NPPs in the public domain databases of protein
sequence (e.g. SWISS-PROT) is very small in proportion to the total
number of sequences. When we developed our method of estimating RA
(May 1999), SWISS-PROT contained 79,449 sequences, of which some 57
could denitely be identied as human NPPs.
2. There is no guarantee that all the human NPPs in SWISS-PROT have
been properly identied. We estimate there may, in fact be up to 90
NPPs in SWISS-PROT.
3. There is no benchmark method for NPP recognition that can be used to
compare any new methods. We must therefore compare our recognition
model with random sampling to evaluate success.
This domain requires a performance measure which addresses all of these
issues.
Table 8 summarises how some of the properties of SWISS-PROT changedPut
Tab 8
here
over the duration of the experiments described in this paper. All the RA meas-
urements in this paper are based on the properties as they stood at May 99.
When measuring performance using RA there is no requirement that the size
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of the test data-set is equal to the number of known human NPPs in SWISS-
PROT.
A.1 Limitations of Existing Performance Measures
For domains in which positives are rare, predictive accuracy, as it is normally
measured in Machine Learning (assuming equal misclassication costs):
 gives a poor estimate of the performance of a recognition model. For
instance, if a learner induces a very specic model for such a domain, the
predictive accuracy of the model may be very high despite the number of
true positives being very small or even zero.
 does not discriminate well between models which exclude most of the
(abundant) negatives but cover varying numbers of (the rare) positives.
(This was illustrated earlier in this paper - see Table 6.)
For domains in which there is no benchmark recognition method that can be
used to compare any new methods, Lift (Ling & Li, 1998) is not the appropriate
measure of performance because it does not quantify the reduction in cost in
using the predictor versus random sampling. Furthermore, in their paper, Ling
& Li gave no explanation of how to assess the signicance of the dierence
between the Lift of two models. ROC curves (or Lorentz diagrams) (Provost &
Fawcett, 1998) also do not quantify the reduction in cost in using the predictor
versus random sampling.
Therefore we dene a relative advantage (RA) function which predicts the
reduction in cost in using the model versus random sampling. In contrast to
other performance measures, RA is meaningful and relevant to experts in the
domain.
A.2 Denition of RA
In the following, `the model' refers to the learned recognition model for predict-
ing whether a sequence is a NPP.
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We dene a relative advantage (RA) function which predicts the reduction
in cost in using the model versus random sampling.
RA =
A
B
(1)
where
A = the expected cost of nding one NPP by repeated independent random
sampling from SWISS-PROT and performing a laboratory analysis of each
protein.
B = the expected cost of nding one NPP by repeated independent random
sampling from SWISS-PROT and analysing only those proteins which are
predicted by the learned model to be a NPP.
RA can be dened in terms of probability as follows. Let
C = the cost of testing the biological activity of one protein via wet-experiments
in the laboratory;
NPP = Sequence is a NPP;
Rec = Model recognises sequence as a NPP.
Equation 1 can now be rewritten as:
RA =
C=Pr(NPP )
C=Pr(NPP j Rec)
=
Pr(NPP j Rec)
Pr(NPP )
(2)
Let testing the model on test data yield the 2 2 contingency table shown
in Table 9 with the cells n
1
, n
2
, n
3
, and n
4
. Let n = n
1
+ n
2
+ n
3
+ n
4
bePut
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the number of instances in the test-set. Note that the random set of sequences
referred to in the right-hand column may include some NPP sequences. Table 10
shows an estimate of the contingency table that would be obtained if it werePut
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possible to identify and remove all the positives from the set of randoms. If the
proportion of NPPs in the test-set was known to be the same as the proportion
of NPPs in the database then we could estimate Pr(NPP ) to be (n
1
+ n
3
)=n
and Pr(NPP j Rec) to be n
1
=(n
1
+ n
2
). These estimates cannot be used with
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our method because we cannot assume that the proportion of NPPs is the same
in the test-set and database.
In order to derive a formula for estimating RA given both a set of positives
and a set of randoms, we estimate Pr(NPP ) and Pr(NPP j Rec) as follows.
Let S be the total number of sequences in the database, of which M are NPPs.
Pr(NPP ) =
no: of NPPs in the database
no: of sequences in the database
= M=S (3)
Pr(NPP j Rec) =
N
db NPP recog
N
db seq pred pos
(4)
where N
db NPP recog
is the number of NPPs in db which are recognised by
model and N
db seq pred pos
is the number of sequences in db which the model
predicts to be NPP.
Table 11 shows the expected result of using the learned recognition modelPut
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on the entire SWISS-PROT database. Note that the factor (1   Æ) does not
appear as it cancels out. From Equation 4 and Table 11 it follows that:
Pr(NPP j Rec) '

n
1
n
1
+n
3

M

n
1
n
1
+n
3

M +

n
2
n
2
+n
4

(S  M)
= (Mp
1
)=(Mp
1
+ (S  M)p
2
) (5)
where p
1
= n
1
=(n
1
+ n
3
) and p
2
= n
2
=(n
2
+ n
4
). Substituting Equations 3 and
5 into Equation 2 gives
RA =
(Mp
1
)=(Mp
1
+ (S  M)p
2
)
M=S
=
Sp
1
Mp
1
+ (S  M)p
2
=
Sp
1
Sp
2
+M(p
1
  p
2
)
(6)
A.3 Estimating Relative Advantage
In the following Relative Advantage over the entire population is represented
by RA in capital letters where as Relative Advantage over a sample is denoted
by lower case i.e. ra. As the value of M is not known, we estimate
P
90
M=57
RA.
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Therefore we integrate Equation 6 with respect to M. The lower limit of M
is equal to the number of known NPPs in SWISS-PROT. The upper limit of
M is the most probable number of NPPs in SWISS-PROT i.e. a total of the
known NPPs and those proteins which have yet to be scientically recognised
as a NPP.
90
X
M=57
RA ' Sp
1

Z
91
M=57
1
(p
1
  p
2
)M + Sp
2
@M
=

Sp
1
(p
1
  p
2
)
ln((p
1
  p
2
)M + Sp
2
) + k

91
57
=
Sp
1
(p
1
  p
2
)
ln
91(p
1
  p
2
) + Sp
2
57(p
1
  p
2
) + Sp
2
(7)
We estimate
P
90
M=57
RA by summing an estimate of the
P
90
M=57
RA for each
instance in the test-set as follows, where n is the number of instances in the
test-set. This method has the advantage that it allows the signicance of the
dierence between the RA of two models to be gauged (see Section A.4).
n
X
k=1
90
X
M=57
ra
k
(8)
From Equation 8 and the contingency table it follows that:
90
X
M=57
ra =
1
n
4
X
i=1
 
n
i
90
X
M=57
ra
i
!
(9)
Each
P
90
M=57
ra
i
is estimated by substituting p
1
=
a
a+c
and p
2
=
b
b+d
into
Equation 7. The values of a, b, c and d are determined by three steps.
1. Whatever the i value, a, b, c and d are initially given the values of the
corresponding counts/frequencies in the contingency table for the test-set
(see Table 9).
2. Each one of a, b, c and d, is decremented providing that the value before
subtraction is greater than 1.
We do not decrement when the value before subtraction is zero because
this can result in p
1
or p
2
having negative values; this does not make sense
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because p
1
and p
2
are probabilities. We do not decrement when the value
is one because this can cause p
1
or p
2
to have the value zero, which in
turn has a highly disproportionate eect on the value of
P
90
M=57
ra
i
.
3. The value of either a, b, c or d is incremented to reect the classication
of an instance in the cell n
i
.
For instance, if i = 2 and all the counts in the contingency table are greater
than one then a = n
1
  1; b = n
2
; c = n
3
  1; d = n
4
  1.
Note that Steps 1 and 2 assign the same prior probability to each instance
because the eect of each step is not dependent upon which cell the current
instance belongs to. Therefore this method of estimating
P
90
M=57
RA has the
properties of a) producing identically distributed random variables representing
the outcome for each instance; b) having a sample mean which approaches the
population mean in the limit and c) having a relatively small sample variance.
The nal step of our method for estimating RA is to take the mean of the
summed values.
Mean RA =
P
90
M=57
ra
i
90  (57  1)
=
P
90
M=57
ra
i
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(10)
A.4 Assessing the signicance of the dierence between
the RA of two models
Next we develop a method for assessing the signicance of the dierence between
the RA of two models. This method tackles a problem which is similar to that
posed by the third question in Dietterich's taxonomy of statistical questions in
Machine Learning (Dietterich, 1998). That is, how to choose between classiers
for a single application domain in which the amount of available data is suÆ-
cient to allow some of it to be set aside for evaluating classiers. However a
new method is needed because of the fundamental dierences between Relative
Advantage and predictive accuracy.
We compare the performance of two recognition models, H
1
and H
2
, by
comparing their
P
90
M=57
RA values. Let d be dierence in
P
90
M=57
RA values
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over the entire population, i.e. for all the proteins in SWISS-PROT, and
^
d be
the observed dierence on the test-set.
d =
90
X
M=57
RA
H
1
 
90
X
M=57
RA
H
2
(11)
^
d =
90
X
M=57
ra
H
1
 
90
X
M=57
ra
H
2
(12)
^
d is an unbiased estimator for the true dierence because it is calculated using
an independent test-set. To determine whether the observed dierence is stat-
istically signicant we address the following question. What is the probability
that
P
90
M=57
RA
H
1
>
P
90
M=57
RA
H
2
, given the observed dierence,
^
d.
If D is a random variable representing the outcome of estimating d by ran-
dom sampling then, according to the Central Limit Theorem, ^
D
is normally dis-
tributed in the limit. It has an estimated mean
^
d and has an estimated variance
of ^
2
D
=n. The variance of a random variable, X, is 
2
X
= E((X)
2
)   (E(X))
2
.
Therefore, since D is a random variable:
^
2
D
= ^
D
2
  ^
2
D
(13)
We calculate ^
D
2
as follows. Let testing the model on test data yield the
4 4 contingency table shown in Table 12 with the cells n
i;j
.Put
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^
D
2
=
1
n
4
X
i=1
4
X
j=1
0
@
n
i;j
 
90
X
M=57
ra
i
 
90
X
M=57
ra
j
!
2
1
A
(14)
Given that p(
P
90
M=57
RA
H
1
>
P
90
M=57
RA
H
2
) = p(
P
90
M=57
RA
H
1
 
P
90
M=57
RA
H
2
>
0) we evaluate our null hypothesis by estimating p(d < 0) using the Central
Limit Theorem.
Z
0
x= 1
Pr(d = x)dx =
Z
0
x= 1
1
p
2
2
e
 
1
2
(
x 

)
2
dx (15)
where  = ^
D
and  = ^
D
=
p
n.
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B CProgol and the Production Rules Generated
Table 13 shows the production rules generated by CProgol. The rules comply
with Prolog syntax. signal(X;Y ) is true if there is a signal peptide at the be-
ginning of the sequence X , and it is followed by a sequence Y . The other dyadic
predicates are dened similarly. Non-terminals and terminals which appear on
the right hand side of the production rules listed in Table 13 are dened in
Table 14. Table 14 shows the Prolog code representing the background know-
ledge input to Progol. The production rules, when taken together with the
partial grammar shown in Figure 3, form a grammar for NPP sequences.
B.1 Dening a Hypothesis Language for Progol
A Hypothesis Language for Progol is dened by:{
 mode and type declarations which state the forms that atoms in hypo-
theses may take (see Sections B.1.1 and B.1.2);
 prune declarations which further restrict the form of hypotheses (see Sec-
tion B.1.3);
 the maximum number of layers of variables introduced by atoms in the
body of induced clauses from variables in the head of the clauses;
 the maximum number of literals in the body of induced clauses.
The hypothesis language used in the experiment is dened by Tables 15, 16
and 17.
B.1.1 Mode Declarations
The mode declarations state the mode of call for those predicates that can
appear in a hypothesis induced by Progol. There are two types of mode declar-
ations, as shown below. The rst describes the form of literals that may appear
in the head of clauses induced by Progol and the second describes those that
may appear in the body.
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:- modeh(Recall number, Head template)?
:- modeb(Recall number, Body literal template)?
Head template and Body literal template are templates of predicates and
take the form predicate(ts1, ts2, ...), where ts is a term specication.
Each term specication comprises two parts: a mode and a type. Types are
described in Section B.1.2. The three possible modes are:{
+ This indicates that the term is an input. That is, in all calls to this predicate,
the term will be bound to a value.
{ This indicates the term is an output.
# This indicates that a constant should appear in this term.
Recall number refers to the determinacy of the predicate template, that is
it species the maximum number of times a call to the predicate can succeed
for a given set of input variables. Hence for determinate predicate templates it
is set to one and for indeterminate predicate templates to values greater than
one. If the User species a Recall number to be * then Progol assigns a default
value of 100 to it.
B.1.2 Type Declarations
Types that are included in mode declarations may be unary predicates dened
in the background knowledge. All but one of the mode declarations listed in
Table 15 refer to the type rlist/1; this is a predicate whose denition is listed
on Table 14. Progol type-checks a constant by executing a query in which the
predicate corresponds to the type and the term is instantiated to the constant.
If the query succeeds then Progol accepts that the constant is of the correct
type.
B.1.3 Prune Declarations
Prune declarations are used to prevent Progol considering specied forms of
clauses. A declaration is made by the User dening the predicate prune(Head,
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Body). Progol will not consider a clause if a call to prune(Head, Body) succeeds
when Head is instantiated to the literal in the head of the proposed clause and
Body is instantiated to the proposed body of the clause.
B.2 The Time and Space Complexity of Progol
The Progol algorithm, as analysed in (Muggleton, 1995), has time and space
complexity which increases linearly in both the number of examples and the
number of clauses in the learned theory. However, the scaling constants involved
vary depending on the size of the hypothesis space searched for each clause. This
is controlled using a number of parameters, including a clause length bound and
a proof depth bound.Put
Tables
13, 14, 15,
16, 17
here
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C Rule-sets generated by C4.5 and C4.5 rules
The rule-set that was generated from the `Proportions + Length + SIGNALP
+ Grammar' amalgam is shown in Figures 5 and 6. Each box contains a rule as
it was output by C4.5rules together with the English translation which is shown
in italics. The percentage in square brackets refers to the predicted accuracy
of the corresponding rule. Each column of rules is tried in turn. Within each
column, each rule is tried in order of appearance . The last rule is the `default'
rule which is used if none of the other rules apply.
The rule-set that was generated from the `Proportions + Length' amalgam
is shown in Figures 7, 8 and 9.Put
Figures
5, 6, 7,
8, 9
here
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Table 1: SWISS-PROT identiers for the NPPs in the training-set.
P01019 P01042 P01156 P01178 P01185 P01189 P01210 P01213 P01258 P01270 P01275
P01279 P01282 P01286 P01298 P01303 P05060 P05305 P06881 P07491 P08858 P08949
P10082 P10645 P12272 P14138 P16860 P18509 P20366 P20382 P20800 P21591 P22466
P35318
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Table 2: SWISS-PROT identiers for the NPPs in the test-set.
P01148 P01160 P01166 P06307 P06850 P10997 P13521 P23582 P20396 P01350
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Table 3: Physical and chemical properties of the amino acids.
Physicochemical Property Amino acids with property
Hydrophobic H,W,Y,F,M,L,I,V,C,A,G,T,K
Very hydrophobic A,F,G,I,L,M,V
Hydrophilic S,E,Q,R,D,N
Electropositive R,K,H
Electronegative D,E
Neutral A,C,F,G,I,L,M,N,P,Q,S,T,V,W,Y
Large Q,E,R,K,H,W,Y,F,M,L,I
Small P,V,C,A,G,T,S,N,D
Tiny A,G,S
Polar Y,T,S,N,D,E,Q,R,K,H,W
Aliphatic L,I,V
Aromatic H,W,Y,F
Hydrogen donor W,Y,H,T,K,C,S,N,Q,R
Hydrogen acceptor Y,T,C,S,D,E,N,Q
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Table 4: The grammar group of features.
Feature Description
gram pred A boolean which indicates whether the grammar predicts a
sequence to be a NPP or not.
gram sig l Length of the signal peptide.
gram np l Length of the neuropeptide.
gram first Position of the rst residue in the neuropeptide.
gram last Position of the last residue in the neuropeptide.
gram np start first The rst residue in the neuropeptide or one of its properties.
gram np start secondThe second residue in neuropeptide or one of its properties.
gram np end first The rst residue/property/star in the body of the end rule.
gram np end second The second residue/property/star in the body of the end
rule.
gram np end third The third residue/property/star in the body of the end rule.
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Table 5: The SIGNALP group of features
Feature Description
sigp cmax Maximum SIGNALP C score
sigp cmaxpos Position where maximum SIGNALP C score is achieved
sigp cconcl SIGNALP C score conclusion (`y' or `n')
sigp ymax Maximum Y score reported by SIGNALP
sigp ymaxpos Position where maximum SIGNALP Y score is achieved
sigp yconcl SIGNALP Y score conclusion (`y' or `n')
sigp smax Maximum SIGNALP S score
sigp smaxpos Position where maximum SIGNALP S score is achieved
sigp sconcl SIGNALP S score conclusion (`y' or `n')
sigp smean SIGNALP mean of S scores to cleavage site
sigp smeanconcl SIGNALP mean S score conclusion
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Table 6: Estimates of Mean RA and predictive accuracy of both the HMM and
the decision trees generated from the amalgams of the feature groups. Mean RA
was estimated using the method described in Section A.3.
Predictor MeanRA Predictive Accuracy (%)
Hidden Markov Model 0 99.0
+
 
0.3
Only props 0 96.7
+
 
0.6
Only Length 1.6 91.8
+
 
0.9
Only SignalP 11.7 98.1
+
 
0.4
Only Grammar 10.8 97.0
+
 
0.5
Props + Length 49.0 98.6
+
 
0.4
Props + SignalP 15.0 98.3
+
 
0.4
Props + Grammar 31.7 98.2
+
 
0.4
SignalP + Grammar 0 98.6
+
 
0.4
Length + Grammar 0 96.2
+
 
0.6
Length + SignalP 34.4 98.7
+
 
0.4
Length + SignalP + Grammar 0 98.0
+
 
0.4
Props + Length + SignalP 29.2 98.7
+
 
0.4
Props + Length + Grammar 33.2 98.5
+
 
0.4
Props + SignalP + Grammar 15.0 98.3
+
 
0.4
Props + Length + SignalP + Grammar 107.7 99.0
+
 
0.3
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Table 7: SWISS-PROT identiers for the additional 13 NPPs which had been
added to SWISS-PROT by May 1999.
P10092 P23435 O00230 P09681 O43555 P07492 P48645 P01138 P20783 P02818
Q13519 Q00072 P55089
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Table 8: Properties of sequences in SWISS-PROT in Spring 1997 and in May
1999.
Spring 1997 May 1999
Number of sequences 64,000 79,449
Number of known human NPPs 44 57
Most probable number of human NPPs Not known 90
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Table 9: 2 2 Contingency table for the test-set. The axes of the 2 2 matrix
are labelled by the sets NPP sequences, Random sequences, H (Hypothesis
predictions) and H (complement of H). The cells of the matrix represent the
cardinalities of the corresponding intersections of these sets. n
1
+n
2
+n
3
+n
4
=
n, where n is the number of instances in the test-set.
Set of test NPP sequences Set of test Random sequences
H n
1
n
2
H n
3
n
4
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Table 10: 22 Contingency table for the positives and negatives in the test-set.
The axes of the 2 2 matrix are labelled by the sets NPP sequences, Negative
sequences, H (Hypothesis predictions) and H (complement of H). The cells
of the matrix represent the cardinalities of the corresponding intersections of
these sets. Æ = M=S where S is the total number of sequences in the entire
SWISS-PROT database, of which M are NPPs.
Set of test NPP sequences Set of test Negative sequences
H n
1
n
2
(1  Æ)
H n
3
n
4
(1  Æ)
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Table 11: 22 Contingency table for SWISS-PROT. The axes of the 22 matrix
are labelled by the sets NPP sequences, Random sequences, H (Hypothesis
predictions) and H (complement of H). The total of the counts/frequencies in
the four cells = S, where S is the total number of sequences in the SWISS-PROT
database.
NPP sequences in SWISS-PROT Negative sequences in SWISS-PROT
H

n
1
n
1
+n
3

M

n
2
n
2
+n
4

(S  M)
H

n
3
n
1
+n
3

M

n
4
n
2
+n
4

(S  M)
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Table 12: 4 4 Contingency Table. The rows of the 4  4 matrix are labelled
by the cells of the 2  2 contingency table for H
1
. The columns of the 4  4
matrix are labelled by the cells of the 2 2 contingency table for H
2
. The cells
of the 44 matrix represent the cardinalities of the corresponding intersections
of these sets.
P
4
i=1
P
4
j=1
n
i;j
= n, where n is the number of instances in the
test-set.
n
1
n
2
n
3
n
4
n
1
n
1;1
n
1;2
n
1;3
n
1;4
n
2
n
2;1
n
2;2
n
2;3
n
2;4
n
3
n
3;1
n
3;2
n
3;3
n
3;4
n
4
n
4;1
n
4;2
n
4;3
n
4;4
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Table 13: Production Rules Generated by CProgol
sigpep(A,B) :- g(A,C), star(C,D), s(D,B).
sigpep(A,B) :- m(A,C), star(C,D), hydrophilic(D,E), tiny(E,B).
sigpep(A,B) :- hydrophobic(A,C), star(C,D), w(D,E), hydro b acc(E,B).
sigpep(A,B) :- large(A,C), run(C,D,hydrophobic), star(D,E), t(E,B).
sigpep(A,B) :- m(A,C), star(C,D), t(D,E), neutral(E,F), small(F,B).
sigpep(A,B) :- m(A,C), star(C,D), very hydrophobic(D,E), positive(E,F), tiny(F,B).
sigpep(A,B) :- hydrophobic(A,C), run(C,D,hydrophobic), star(D,E), f(E,F), hydrophobic(F,B).
sigpep(A,B) :- hydrophobic(A,C), star(C,D), h(D,E), hydrophobic(E,F), tiny(F,B).
sigpep(A,B) :- hydrophobic(A,C), star(C,D), v(D,E), hydrophobic(E,F), neutral(F,B).
sigpep(A,B) :- large(A,C), star(C,D), a(D,E), hydrophobic(E,F),small(F,B).
sigpep(A,B) :- large(A,C), star(C,D), s(D,E), neutral(E,F), small(F,B).
start(A,B) :- a(A,C), very hydrophobic(C,B).
start(A,B) :- d(A,C), t(C,B).
start(A,B) :- g(A,C), v(C,B).
start(A,B) :- h(A,C), r(C,B).
start(A,B) :- k(A,C), r(C,B).
start(A,B) :- l(A,C), r(C,B).
start(A,B) :- q(A,C), g(C,B).
start(A,B) :- s(A,C), l(C,B).
start(A,B) :- w(A,C), q(C,B).
start(A,B) :- hydrophilic(A,C), a(C,B).
start(A,B) :- hydrophilic(A,C), hydrophilic(C,B).
start(A,B) :- positive(A,C), k(C,B).
start(A,B) :- small(A,C), r(C,B).
middle(A,B) :- yvh(A,C), star(C,D), large(D,E), large(E,B).
middle(A,B) :- positive(A,C), star(C,D), neutral(D,E), large(E,F), large(F,B).
middle(A,B) :- hydro b acc(A,C), star(C,D), hydrophobic(D,E),neutral(E,F), aromatic(F,B).
middle(A,B) :- hydro b acc(A,C), yvh(C,D), star(D,B).
middle(A,B) :- small(A,C), star(C,D), p(D,E), large(E,F), large(F,B).
middle(A,B) :- y(A,C), star(C,D), g(D,E), hydrophobic(E,B).
middle(A,B) :- hydro b acc(A,C), star(C,D), k(D,E), neutral(E,F), small(F,B).
middle(A,B) :- small(A,C), star(C,D), l(D,E), m(E,B).
middle(A,B) :- small(A,C), star(C,D), f(D,E), hydrophobic(E,F),aliphatic(F,B).
middle(A,B) :- tiny(A,C), star(C,D), m(D,B).
middle(A,B) :- q(A,C), star(C,D), positive(D,E), neutral(E,F),neutral(F,B).
middle(A,B) :- hydrophobic(A,C), star(C,D), m(D,E), hydrophilic(E,F), neutral(F,B).
middle(A,B) :- e(A,C), star(C,D), i(D,B).
middle(A,B) :- q(A,C), star(C,D), l(D,B).
middle(A,B) :- aromatic(A,C), star(C,D), v(D,E), neutral(E,F),hydro b don(F,B).
middle(A,B) :- aromatic(A,C), star(C,D), a(D,E), e(E,B).
middle(A,B) :- c(A,C), star(C,D), c(D,B).
middle(A,B) :- y(A,C), star(C,D), hydro b don(D,E), hydro b don(E,B).
middle(A,B) :- hmn(A,C), star(C,D), d(D,B).
middle(A,B) :- tiny(A,C), star(C,D), l(D,E), hydro b don(E,F),hydro b don(F,B).
middle(A,B) :- neutral(A,C), star(C,D), very hydrophobic(D,E),negative(E,F), aromatic(F,B).
middle(A,B) :- h(A,C), star(C,D), very hydrophobic(D,E), neutral(E,B).
middle(A,B) :- h(A,C), star(C,D), positive(D,E), neutral(E,F),hydro b don(F,B).
middle(A,B) :- hydrophilic(A,C), star(C,D), e(D,E), small(E,B).
middle(A,B) :- hydro b don(A,C), star(C,D), g(D,E), hydrophobic(E,F), neutral(F,B).
middle(A,B) :- hydrophobic(A,C), star(C,D), n(D,E), neutral(E,F), large(F,B).
middle(A,B) :- hydrophobic(A,C), star(C,D), a(D,E), f(E,B).
middle(A,B) :- hydro b don(A,C), star(C,D), negative(D,E), aromatic(E,B).
middle(A,B) :- hydro b acc(A,C), star(C,D), r(D,E), hydrophobic(E,B).
middle(A,B) :- aromatic(A,C), star(C,D), a(D,E), very hydrophobic(E,F), large(F,B).
middle(A,B) :- tiny(A,C), star(C,D), r(D,E), tiny(E,B).
end(A,B) :- pp(A,C), d(C,B).
end(A,B) :- pp(A,C), large(C,B).
end(A,B) :- e(A,C), l(C,D), s(D,B).
end(A,B) :- e(A,C), v(C,D), v(D,B).
end(A,B) :- g(A,C), positive(C,D),
hydro b don(D,B).
end(A,B) :- q(A,C), a(C,D), g(D,B).
end(A,B) :- r(A,C), tiny(C,D), hydro b acc(D,B).
end(A,B) :- t(A,C), neutral(C,D), hydro b acc(D,B).
end(A,B) :- positive(A,C), r(C,D), small(D,B).
end(A,B) :- positive(A,C), r(C,D), hydro b acc(D,B).
end(A,B) :- large(A,C), l(C,D), v(D,B).
end(A,B) :- small(A,C), hydrophobic(C,D), positive(D,B).
end(A,B) :- tiny(A,C), star(C,D), r(D,B).
end(A,B) :- aliphatic(A,C), n(C,D), t(D,B).
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Table 14: Background Knowledge Predicates. The ground instantiations of the
unary predicates representing the properties shown in Table 3 are not shown
here for reasons of space.
rlist([]).
rlist([RjT]) :- res(R), rlist(T).
res(a). res(b). res(c). ... res(z).
any([ jS],S). % residue of any type or property
kr(A,C) :- k(A,B), r(B,C). kp(A,C) :- k(A,B), positive(B,C).
pp(A,C) :- positive(A,B), positive(B,C). gkr(A,D) :- g(A,B), k(B,C), r(C,D).
grr(A,D) :- g(A,B), r(B,C), r(C,D). yvh(A,C) :- y(A,B), very hydrophobic(B,C).
hp(B,C) :- h(B,C), p(C,D).
hmn(A,E) :- hydrophilic(A,B), star(B,C), m(C,D), negative(D,E).
wmdf(A,B) :- w(A,C), m(C,D), d(E,F), f(F,B), end(B).
very hydrophobic([RjT],T):- very hydrophobic(R). small([RjT],T):- small(R).
hydrophobic([RjT],T):- hydrophobic(R). tiny([RjT],T):- tiny(R).
hydrophilic([RjT],T):- hydrophilic(R). polar([RjT],T):- polar(R).
positive([RjT],T):- positive(R). aliphatic([RjT],T):- aliphatic(R).
negative([RjT],T):- negative(R). aromatic([RjT],T):- aromatic(R).
neutral([RjT],T):- neutral(R). hydro b don([RjT],T):- hydro b don(R).
large([RjT],T):- large(R). hydro b acc([RjT],T):- hydro b acc(R).
star(S,S).
star([ jS],T) :- star(S,T).
a([ajT],T). b([bjT],T). c([cjT],T). ... z([zjT],T).
run([XjS],T,P) :- prop(P), docall(P,X), run(S,T,P).
run([X,YjS],S,P) :- prop(P), docall(P,X), docall(P,Y).
docall(P,X) :- Call=.. [P,X], Call.
prop(very hydrophobic). prop(hydrophobic). prop(hydrophilic).
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Table 15: Mode Declarations Used During Training with CProgol.
TARGET PREDICATE is either sigpep, start, middle or end.
:- modeh(1,TARGET_PREDICATE(+rlist,-rlist))?
:- modeb(1,yvh(+rlist,-rlist))? :- modeb(*,hmn(+rlist,-rlist))?
:- modeb(1,hp(+rlist,-rlist))? :- modeb(1,wmdf(+rlist,-rlist))?
:- modeb(1,a(+rlist,-rlist))? :- modeb(1,b(+rlist,-rlist))? ... :- modeb(1,z(+rlist,-rlist))?
:- modeb(1,hydrophobic(+rlist,-rlist))? :- modeb(1,small(+rlist,-rlist))?
:- modeb(1,very_hydrophobic(+rlist,-rlist))? :- modeb(1,tiny(+rlist,-rlist))?
:- modeb(1,hydrophilic(+rlist,-rlist))? :- modeb(1,tiny(+rlist,-rlist))?
:- modeb(1,positive(+rlist,-rlist))? :- modeb(1,aliphatic(+rlist,-rlist))?
:- modeb(1,negative(+rlist,-rlist))? :- modeb(1,aromatic(+rlist,-rlist))?
:- modeb(1,neutral(+rlist,-rlist))? :- modeb(1,hydro_b_don(+rlist,-rlist))?
:- modeb(1,large(+rlist,-rlist))? :- modeb(1,hydro_b_acc(+rlist,-rlist))?
% The next five mode declarations were only used when generating rules for the ends.
:- modeb(1,pp(+rlist,-rlist))? :- modeb(1,gkr(+rlist,-rlist))?
:- modeb(1,kp(+rlist,-rlist))? :- modeb(*,run(+rlist,-rlist,#prop))?
:- modeb(1,kr(+rlist,-rlist))?
% The next mode declaration was only used when generating rules for signals, middles and ends.
:- modeb(*,star(+rlist,-rlist))?
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Table 16: Prune Predicates Used During Training with CProgol.
TARGET PREDICATE is either sigpep, start, middle or end.
prune(_,Body):- in(star(A,B),Body), A==B. % No star(X,X) in body
prune(Head,Body):- Head=.. [_,U,_], not(chain(U,Body)). % Body must form variable chain from head
prune(_,Body):- suffix(Body,Suffix), % No star(X,Y),star(Y,Z) in body
(Suffix=(star(_,_),(star(_,_),_))
; Suffix=(star(_,_),(star(_,_))) ).
% The following prune was not used when generating the rules for the starts or middles.
prune(_,Body):- suffix(Body,Suffix), % No run(X,Y),run(Y,Z) in body
( Suffix=(run(_,_,P),(run(_,_,P),_))
; Suffix=(run(_,_,P),(run(_,_,P))) ).
% The following prune was not used when generating the start rules.
prune(_,star(_,_)).
:- TARGET_PREDICATE(x,y). % Not allowed everything a NPP
chain(U,true).
chain(U,A):- A=.. [_,V,_|_], U==V.
chain(U,(A,B)):- A=.. [_,V,W|_], U==V, chain(W,B).
suffix(S,S).
suffix((_,S),S1):- suffix(S,S1).
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Table 17: CProgol Settings Used for Training
pos inate i c nodes v h r s
signal yes 100000 6 5 4000 0 100000000 100000000 100000000
start yes 100000 6 5 4000 0 100000000 100000000 100000000
middle yes 100000 6 5 1000 0 200 400 100000000
end yes 100000 3 3 4000 0 100000000 100000000 100000000
pos The posonly setting. When this is set to yes CProgol adopts the ILP Bayesian approach to
learning from positive examples.
inate Controls the specicity of clauses obtained.
i An upper bound on the number of layers of variables introduced by atoms in the body of induced
clauses from variables in the head of the clauses.
c An upper bound on the number of literals in the body of induced clauses.
nodes An upper bound on the nodes to be explored by CProgol when searching for a consistent
clause.
v The verbosity of the output.
h A depth bound on the theorem prover.
r An upper bound on the number of resolutions beyond which the whole proof fails i.e. backtracking
does not occur.
s Size of the unication stack in bytes.
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Figure 1: A neuropeptide precursor sequence containing the Angiotensin
neuropeptides. A precursor will always contain exactly one signal peptide. The
number of neuropeptides can vary.
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First author is S.H.Muggleton. "
Figure 2: Some of the dierent congurations of neuropeptides known to occur
within human precursors. Precursor (i) shows a single cleaved peptide anked by
ller of unknown function. Precursor (ii) shows three dierent cleaved peptides,
two of which are adjacent to each other, whilst the other is separated by ller.
Precursor (iii) contains the same short peptide repeated 4 times. Precursor
(iv) shows that cleavage can occur selectively, giving alternative termini to the
released peptides.
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npp(A,B):- signal(A,C),
star(C,D),
neuro_peptide(D,E),
star(E,B).
signal(A,C):- ...
neuro_peptide(D,E):- start(D,F),
middle(F,G),
end(G,E).
start(D,F):- ...
middle(F,G):- ...
end(G,E):- ...
m
B
k p i ... k r d a g k r ...
A
signal
star
C
D
start
middle
F
G
end E
star
First author is S.H.Muggleton. "
Figure 3: Grammar rules describing legal NPP sequences. The rules comply
with Prolog syntax. npp(X;Y ) is true if there is a precursor at the beginning of
the sequence X , and it is followed by a sequence Y . The other dyadic predicates
are dened similarly. star(X;Y ) is true if, at the beginning of the sequence X ,
there is some sequence of residues whose length is not specied and which is
followed by another sequence Y . Denitions of the predicates denoted by `...'
are to be learnt from data of known NPP sequences.
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Filter
Using our best recognition model as a filter 
Random
Sample
Sample using
Model
SWISS-PROT
SWISS-PROT
NPPs
novel
1 : 22
NPPs
1 : 8
NPPs
novel1 : 883NPPs
1 : 2408
First author is S.H.Muggleton. "
Figure 4: The advantage of using our best recognition model to search for a
novel NPP in SWISS-PROT. If one searches for a NPP by randomly selecting
sequences from SWISS-PROT for synthesis and subsequent biological testing
then, at most, only one in every 2408 sequences tested is expected to be a novel
NPP. Using our best recognition model as a lter makes the search for a NPP
far more eÆcient. Approximately one in every 22 of the randomly selected
SWISS-PROT sequences which pass through our lter is expected to be a novel
NPP. To put this in terms of the economies of the search for new and valuable
neuropeptides our best predictor delivers more than a hundred-fold saving.
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Rule 1:
sigp ymax <= 0.457
-> class 0 [99.9%]
A sequence is not a NPP if the
maximum Y score reported by
SIGNALP  0:457.
Rule 31:
length > 267
proportion l <= 0.141717
proportion polar <= 0.285366
-> class 0 [99.9%]
A sequence is not a NPP if
it is more than 267 residues
long and the proportion of its
residues which are:- 1) leucine
(L) is  0:141717 2) polar is
 0:285366.
Rule 14:
gram np start first = 0
proportion h > 0.00588235
proportion i > 0.0141343
proportion neutral <= 0.793103
proportion tiny > 0.208253
-> class 0 [99.9%]
A sequence is not a NPP
if the grammar predicts that
a neuropeptide start is not
present and the proportion of
residues in the sequence which
are: 1) histidine (H) is >
0:00588235; 2) isoleucine (I) is
> 0:0141343; 3) not surroun-
ded by an electrostatic charge
is  0:793103; 4) tiny is >
0:208253.
Rule 29:
sigp cmaxpos > 29
proportion r > 0.047043
-> class 0 [99.8%]
A sequence is not a NPP if the
position where maximum SIG-
NALP C score is achieved is
> 29 and the proportion of
its residues which are Arginine
(R) is > 0:047043
Rule 11:
proportion g > 0.040555
proportion r > 0.047043
proportion hydrophobic > 0.584906
proportion tiny <= 0.208253
-> class 0 [99.7%]
A sequence is not a NPP if
the proportion of its residues
which are:- 1) glycine (G) is
> 0:040555; 2) arginine (R)
is > 0:047043; 3) hydrophobic
is > 0:584906; 4) tiny is 
0:208253.
Rule 27:
sigp cmaxpos <= 29
proportion hydrophobic > 0.636591
proportion tiny <= 0.301205
-> class 0 [99.7%]
A sequence is not a NPP if the
position where maximum SIG-
NALP C score is achieved is
 29 and the proportion of its
residues which are:- 1) hydro-
phobic is > 0:636591; 2) tiny
 0:301205.
Rule 5:
proportion tiny <= 0.176282
-> class 0 [99.7%]
A sequence is not a NPP if the
proportion of its residues which
are tiny is  0:176282.
Rule 4:
length <= 267
proportion r <= 0.047043
-> class 0 [99.6%]
A sequence is not a NPP if the
number of residues in the se-
quence is  267 and the pro-
portion of its residues which
are arginine (R) is  0:047043.
Rule 9:
gram sig l <= 25
proportion g > 0.040555
proportion q > 0.0395683
proportion r > 0.047043
proportion tiny <= 0.208253
-> class 0 [99.6%]
A sequence is not a NPP if
the grammar predicts that the
length of the signal peptide is
 25 and the proportion of its
residues which are:- 1) glycine
(G) is > 0:040555; 2) glutam-
ine (Q) is > 0:0395683; 3) ar-
ginine (R) is > 0:047043; 4)
tiny is  0:208253.
Rule 26:
proportion i > 0.00882353
proportion hydrophobic <= 0.636591
proportion neutral > 0.793103
-> class 0 [99.5%]
A sequence is not a NPP if
the proportion of its residues
which are:- 1) isoleucine (I) is
> 0:00882353; 2) hydrophobic
is  0:636591; 3) not surroun-
ded by an electrostatic charge
is > 0:793103.
Rule 6:
gram first <= 55
proportion g <= 0.040555
-> class 0 [99.5%]
A sequence is not a NPP if
the grammar predicts that po-
sition of the rst residue in
the neuropeptide is less than
or equal to 55 residues from
the N-terminal and the pro-
portion of residues in the se-
quence which are glycine is 
0:040555.
Rule 23:
gram sig l <= 27
proportion p > 0.0873016
proportion neutral <= 0.793103
-> class 0 [99.4%]
A sequence is not a NPP if
the grammar predicts that the
length of the signal peptide
is  27 and the proportion
of residues in the sequence
which are:- 1) proline (P) is
> 0:0873016; 2) not surroun-
ded by an electrostatic charge
is  0:793103.
Rule 33:
length > 267
proportion l > 0.142268
-> class 0 [98.4%]
A sequence is not a NPP if
it is more than 267 residues
long and the proportion of its
residues which are leucine (L)
is > 0:142268.
Rule 17:
gram np end first = small
proportion very hydrophobic > 0.435146
-> class 0 [96.8%]
A sequence is not a NPP if
the grammar predicts that the
third from last residue in the
neuropeptide is small and the
proportion of residues in the
sequence which are very hydro-
phobic is > 0:435146.
Rule 21:
gram np start first = s
-> class 0 [95.8%]
A sequence is not a NPP if the
grammar predicts that the rst
residue in the neuropeptide is
serine (S).
First author is S.H.Muggleton. "
Figure 5: Rule-set generated from grammar amalgam.
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Rule 20:
gram np start first = q
-> class 0 [75.8%]
A sequence is not a NPP if the
grammar predicts that the rst
residue in the neuropeptide is
glutamine (Q).
Rule 36:
sigp ymax > 0.457
proportion e > 0.160121
-> class 1 [99.3%]
A sequence is a NPP if the
maximum Y score reported by
SIGNALP is > 0:457 and the
proportion of its residues which
are glutamic acid (E) is >
0:160121.
Rule 8:
sigp ymax > 0.457
length <= 267
proportion g > 0.040555
proportion q <= 0.0395683
proportion hydrophobic <= 0.584906
proportion neutral <= 0.793103
proportion tiny <= 0.208253
-> class 1 [99.2%]
A sequence is a NPP if the
maximum Y score reported by
SIGNALP is > 0:457, the se-
quence length is  267, the pro-
portion of its residues which
are:- 1) glycine (G) is >
0:040555; 2) glutamine (Q) is
 0:0395683; 3) hydrophobic is
 0:584906; 4) not surrounded
by an electrostatic charge is 
0:793103; 5) tiny is  0:208253.
Rule 24:
gram sig l > 27
sigp cmaxpos <= 29
sigp ymax > 0.457
proportion hydrophobic <= 0.636591
proportion neutral <= 0.793103
proportion tiny > 0.208253
-> class 1 [99.2%]
A sequence is a NPP if
the grammar predicts that the
length of the signal peptide is
> 27, the position where max-
imum SIGNALP C score is
achieved is  29, the maximum
Y score reported by SIGNALP
is > 0:457 and the propor-
tion of residues in the sequence
which are:- 1) hydrophobic 
0:636591; 2) not surrounded
by an electrostatic charge is 
0:793103; 3) tiny is > 0:208253.
Rule 22:
sigp cmaxpos <= 29
sigp ymax > 0.457
length <= 267
proportion g > 0.040555
proportion p <= 0.0873016
proportion r > 0.047043
proportion hydrophobic <= 0.636591
proportion neutral <= 0.793103
proportion tiny > 0.208253
-> class 1 [98.9%]
A sequence is a NPP if the
position where maximum SIG-
NALP C score is achieved is
 29, the maximum Y score re-
ported by SIGNALP is > 0:457,
the number of residues in the
sequence is  267, the propor-
tion of residues in the sequence
which are:- 1) glycine (G) is
> 0:040555; 2) proline (P) is
 0:0873016; 3) arginine (R) is
> 0:047043; 4) hydrophobic is
 0:636591; 5) not surrounded
by an electrostatic charge is 
0:793103; 6) tiny is > 0:208253.
Rule 28:
sigp ymax > 0.457
proportion r > 0.047043
proportion hydrophobic > 0.636591
proportion tiny > 0.301205
-> class 1 [98.4%]
A sequence is a NPP if the
maximum Y score reported by
SIGNALP is > 0:457, the pro-
portion of residues in the se-
quence which are arginine (R)
is > 0:047043, the propor-
tion of residues in the sequence
which are hydrophobic is >
0:636591 and the proportion of
residues in the sequence which
are tiny is > 0:301205.
Rule 32:
sigp ymax > 0.457
length > 267
proportion l > 0.141717
proportion l <= 0.142268
-> class 1 [98.3%]
A sequence is a NPP if the
maximum Y score reported by
SIGNALP is > 0:457, the num-
ber of residues in the sequence
is > 267 and the proportion of
residues in the sequence which
are leucine (L) is > 0:141717
but  0:142268.
Rule 34:
sigp ymax > 0.457
sigp smaxpos <= 5
length > 267
proportion polar > 0.585366
-> class 1 [98.3%]
A sequence is a NPP if SIG-
NALP reports that the max-
imum Y score is > 0:457 and
the position where maximum S
score is achieved is  5, the
number of residues in the se-
quence is > 267 and the pro-
portion of its residues which
are polar is > 0:585366.
Rule 2:
gram sig l > 24
proportion small <= 0.373913
-> class 1 [98.3%]
A sequence is a NPP if
the grammar predicts that the
length of the signal peptide is
> 24 and the proportion of
residues in the sequence which
are small is  0:373913.
Rule 3:
proportion l > 0.134529
proportion p > 0.0848656
proportion t <= 0.0305344
-> class 1 [97.8%]
A sequence is a NPP if the pro-
portion of its residues which
are:- 1) leucine (L) is >
0:134529; 2) proline (P) is >
0:0848656; 3) threonine (T) is
 0:0305344.
Default class: 0
First author is S.H.Muggleton. "
Figure 6: Rule-set generated from grammar amalgam (continued).
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Rule 28:
length > 267
proportion r > 0.0350515
proportion hydrophobic > 0.47046
-> class 0 [99.9%]
A sequence is not a NPP
if it contains more than 267
residues and the proportion of
its residues which are:- 1) ar-
ginine (R) is > 0:0350515; 2)
hydrophobic is > 0:47046.
Rule 25:
length > 267
proportion q <= 0.0557491
proportion hydrophobic > 0.47046
-> class 0 [99.9%]
A sequence is not a NPP
if it contains more than 267
residues and the proportion
of its residues which are:- 1)
glutamine (Q)  0:0557491; 2)
hydrophobic is > 0:47046.
Rule 16:
proportion a <= 0.0870787
proportion l > 0.0663812
proportion m > 0.00917431
proportion t > 0.0515464
-> class 0 [99.9%]
A sequence is not a NPP if
the proportion of its residues
which are:- 1) alanine (A) is 
0:0870787; 2) leucine (L) is >
0:0663812; 3) methionine (M)
is > 0:00917431; 4) threonine
(T) is 0:0515464.
Rule 12:
length > 185
proportion c <= 0.0215054
proportion aliphatic <= 0.238095
proportion hydro b acc <= 0.427996
-> class 0 [99.9%]
A sequence is not a NPP
if it contains more than 185
residues and the proportion
of its residues which are:- 1)
cysteine (C) is  0:0215054;
2) aliphatic is  0:238095; 3)
hydrogen bond acceptors is 
0:427996 .
Rule 18:
proportion t > 0.0515464
proportion very hydrophobic > 0.374718
proportion aliphatic <= 0.238095
-> class 0 [99.8%]
A sequence is not a NPP if
the proportion of its residues
which are:- 1) threonine (T)
is > 0:0515464; 2) very hy-
drophobic is > 0:374718; 3)
aliphatic is  0:238095.
Rule 27:
length > 267
proportion s > 0.0778443
proportion hydrophobic > 0.47046
-> class 0 [99.8%]
A sequence is not a NPP
if it contains more than 267
residues and the proportion of
its residues which are:- 1) ser-
ine (S) is > 0:0778443; 2) hy-
drophobic is > 0:47046.
Rule 11:
length > 185
proportion k <= 0.0705882
proportion t <= 0.0515464
proportion hydro b acc <= 0.427996
-> class 0 [99.8%]
A sequence is not a NPP
if it contains more than 185
residues and the proportion of
its residues which are:- 1) lys-
ine (K) is  0:0705882; 2)
threonine (T)  0:0515464; 3)
hydrogen bond acceptors is 
0:427996.
Rule 7:
proportion a <= 0.0818386
proportion aromatic > 0.133641
-> class 0 [99.7%]
A sequence is not a NPP if
the proportion of its residues
which are:- 1) alanine (A) is
 0:0818386; 2) aromatic is >
0:133641.
Rule 3:
proportion tiny <= 0.176282
-> class 0 [99.7%]
A sequence is not a NPP if the
proportion of its residues which
are tiny is  0:176282.
Rule 1:
length <= 267
proportion r <= 0.0472245
-> class 0 [99.6%]
A sequence is not a NPP if
it contains fewer than 268
residues and the proportion of
its residues which are arginine
(R) is  0:0472245.
Rule 2:
proportion s <= 0.0514019
-> class 0 [99.6%]
A sequence is not a NPP if the
proportion of its residues which
are serine (S) is  0:0514019.
Rule 20:
proportion r > 0.0472245
proportion negative > 0.044586
proportion aliphatic > 0.238095
-> class 0 [99.5%]
A sequence is not a NPP if
the proportion of its residues
which are:- 1) arginine (R) is
> 0:0472245; 2) negative is
> 0:044586; 3) aliphatic is >
0:238095.
Rule 4:
proportion d <= 0.0222222
-> class 0 [99.3%]
A sequence is not a NPP if
the proportion of its residues
which are aspartic acid is 
0:0222222.
Rule 5:
proportion l <= 0.0663812
proportion hydro b acc <= 0.427996
-> class 0 [99.3%]
A sequence is not a NPP if
the proportion of its residues
which are:- 1) leucine (L) is
 0:0663812; 2) hydrogen bond
acceptors is  0:427996.
Rule 21:
length <= 267
proportion hydro b acc > 0.427996
-> class 0 [99.3%]
A sequence is not a NPP if
it contains fewer than 268
residues and the proportion of
its residues which are hydrogen
bond acceptors is > 0:427996.
Rule 9:
length <= 185
proportion c > 0.0247253
proportion c <= 0.1
proportion t <= 0.0515464
-> class 0 [98.5%]
A sequence is not a NPP if
it contains fewer than 185
residues and the proportion
of its residues which are:- 1)
cysteine (C) is > 0:0247253 but
 0:1; 2) threonine (T) is 
0:0515464.
Rule 22:
proportion m <= 0.0177936
proportion w <= 0.0139276
proportion hydrophobic <= 0.47046
-> class 0 [91.2%]
A sequence is not a NPP if the
proportion of its residues which
are:- 1) methionine (M) is 
0:0177936; 2) tryptophan (W)
 0:0139276; 3) hydrophobic is
 0:47046.
First author is S.H.Muggleton. "
Figure 7: Rule-set generated from `Proportions + Length' amalgam.
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Rule 13:
length > 185
length <= 267
proportion c > 0.0215054
proportion k > 0.0705882
proportion l > 0.0663812
proportion r > 0.0472245
proportion s > 0.0514019
proportion t <= 0.0515464
proportion aliphatic <= 0.238095
-> class 1 [99.6%]
A sequence is a NPP if the pro-
portion of its residues which
are:- 1) cysteine (C) is >
0:0215054; 2) lysine (K) is >
0:0705882; 3) leucine (L) is >
0:0663812; 4) arginine (R) is
> 0:0472245; 5) serine (S) is
> 0:0514019; 6) threonine (T)
is  0:0515464; 7) aliphatic is
 0:238095.
Rule 6:
length <= 185
proportion c <= 0.0247253
proportion d > 0.0222222
proportion l > 0.0663812
proportion r > 0.0472245
proportion s > 0.0514019
proportion t <= 0.0515464
proportion tiny > 0.176282
proportion aliphatic <= 0.238095
proportion aromatic <= 0.133641
proportion hydro b acc <= 0.427996
-> class 1 [99.4%]
A sequence is a NPP if
it contains fewer than 186
residues and the proportion
of its residues which are:- 1)
cysteine (C) is  0:0247253;
2) aspartic acid (D) is >
0:0222222; 3) leucine (L) is
> 0:0663812; 4) arginine (R)
is > 0:0472245; 5) serine (S)
is > 0:0514019; 6) threonine
(T) is  0:0515464; 7) tiny
is > 0:176282; 8) aliphatic is
 0:238095; 9) aromatic is 
0:133641; 10) hydrogen bond
acceptor is  0:427996.
Rule 8:
length <= 185
proportion a > 0.0818386
proportion c <= 0.0247253
proportion d > 0.0222222
proportion l > 0.0663812
proportion r > 0.0472245
proportion s > 0.0514019
proportion t <= 0.0515464
proportion aliphatic <= 0.238095
proportion hydro b acc <= 0.427996
-> class 1 [99.4%]
A sequence is a NPP if
it contains fewer than 186
residues and the proportion
of its residues which are:- 1)
alanine (A) is > 0:0818386; 2)
cysteine (C) is  0:0247253;
3) aspartic acid (D) is >
0:0222222; 4) leucine (L) is >
0:0663812; 5) arginine (R) is
> 0:0472245; 6) serine (S) is
> 0:0514019; 7) threonine (T)
is  0:0515464; 8) aliphatic is
 0:238095; 10) hydrogen bond
acceptor is  0:427996.
Rule 15:
length <= 267
proportion d > 0.0222222
proportion m <= 0.00917431
proportion r > 0.0472245
proportion s > 0.0514019
proportion t > 0.0515464
proportion very hydrophobic <= 0.374718
proportion tiny > 0.176282
proportion hydro b acc <= 0.427996
-> class 1 [99.3%]
A sequence is a NPP if
it contains fewer than 268
residues and the proportion
of its residues which are:-
1) aspartic acid (D) is >
0:0222222; 2) methionine (M)
is  0:00917431; 3) arginine
(R) is > 0:0472245; 4) serine
(S) is > 0:0514019; 5) threon-
ine (T) is > 0:0515464; 6) very
hydrophobic is  0:374718; 7)
tiny is > 0:176282; 8) hydrogen
bond acceptor is  0:427996.
Rule 17:
length <= 267
proportion a > 0.0870787
proportion l > 0.0663812
proportion t > 0.0515464
proportion very hydrophobic <= 0.374718
proportion tiny > 0.176282
proportion hydro b acc <= 0.427996
-> class 1 [99.2%]
A sequence is a NPP if
it contains fewer than 268
residues and the proportion
of its residues which are:- 1)
alanine (A) is > 0:0870787; 2)
leucine (L) is > 0:0663812; 3)
threonine (T) is > 0:0515464;
4) very hydrophobic is 
0:374718; 5) tiny is > 0:176282;
6) hydrogen bond acceptor is
 0:427996.
Rule 10:
length <= 267
proportion c > 0.1
proportion r > 0.0472245
proportion tiny > 0.176282
proportion hydro b acc <= 0.427996
-> class 1 [99.2%]
A sequence is a NPP if
it contains fewer than 268
residues and the proportion
of its residues which are:- 1)
cysteine (C) is > 0:1; 2) ar-
ginine (R) is > 0:0472245; 3)
tiny is > 0:176282; 4) hydrogen
bond acceptor is  0:427996.
Rule 24:
length > 267
proportion w > 0.0139276
proportion hydrophobic <= 0.47046
-> class 1 [98.6%]
A sequence is a NPP if it con-
tains more than 267 residues
and the proportion of its
residues which are:- 1) trypto-
phan (W) is > 0:0139276; 4)
hydrophobic is  0:47046.
First author is S.H.Muggleton. "
Figure 8: Rule-set generated from `Proportions + Length' amalgam (continued).
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Rule 23:
length > 267
proportion m > 0.0177936
proportion hydrophobic <= 0.47046
-> class 1 [98.4%]
A sequence is a NPP if
it contains more than 267
residues and the proportion of
its residues which are:- 1) me-
thionine (M) is > 0:0177936;
2) hydrophobic is  0:47046.
Rule 19:
length <= 267
proportion d > 0.0222222
proportion r > 0.0472245
proportion s > 0.0514019
proportion negative <= 0.044586
proportion aliphatic > 0.238095
-> class 1 [98.3%]
A sequence is a NPP if
it contains fewer than 268
residues and the proportion of
its residues which are:- 1) as-
partic acid (D) is > 0:0222222;
2) arginine (R) is > 0:0472245;
3) serine (S) is > 0:0514019; 4)
surrounded by a negative elec-
trostatic charge is  0:044586;
5) aliphatic is > 0:238095.
Rule 26:
length > 267
proportion q > 0.0557491
proportion r <= 0.0350515
proportion s <= 0.0778443
proportion hydrophobic > 0.47046
-> class 1 [96.3%]
A sequence is a NPP if
it contains more than 267
residues and the proportion
of its residues which are:- 1)
glutamine (Q) > 0:0557491; 2)
arginine (R) is  0:0350515; 3)
serine (S) is  0:0778443; 4)
hydrophobic is > 0:47046.
Default class: 0
First author is S.H.Muggleton. "
Figure 9: Rule-set generated from `Proportions + Length' amalgam (continued).
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